Skip to content

NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy.

Sep 2026 · Applied Biochemistry and Biotechnology · 0 citations · 31 references
Medicine

TL;DR

NOC4L shows promise as a dual-action target, functioning both as a prognostic biomarker and as a potential immunotherapeutic target, and is associated with overall survival in 20 cancer types, suggesting its potential as an independent prognostic marker.

View source

Similar papers

Sep 2026

Abstract A068: Downregulation of MEIS2 in Multiple Cancers and Its Correlation with Improved Overall Survival: A Potential Prognostic Biomarker

The homeobox transcription factor MEIS2 is a crucial regulator of developmental processes, including embryogenesis and neurogenesis. However, its role in cancer progression and prognosis remains poorly understood across various human malignancies. This study evaluated the expression profile of MEIS2 in different canc...

Abdulrahman E. Algarni · 0 citations
Aug 2026

CDC20B Dysregulation: Links to Tumor Prognosis and Immunity.

CDC20B may contribute to tumor progression in a context-dependent manner, with its prognostic impact varying across cancer types, and promoter hypomethylation emerges as a potential epigenetic driver of overexpression.

Hong-Rong Wu, Liang-Li Hong · 0 citations
Open access Oct 2026

Pan-cancer analysis of SPINT2 reveals context-dependent patterns and prognostic relevance across solid cancers

Serine Protease Inhibitor Kunitz type-2 (SPINT2) has been reported to play a role in the progression of various tumor types. This inhibitor is generally described as a tumor suppressor that affects migration and invasion. However, a few recent studies have reported the opposite, suggesting an oncogenic role for SP...

Sónia Pires Celeiro, Márcia Cristina Santos Pereira, C. Borges-Pereira et al. · 0 citations
Open access Sep 2026

Comprehensive pan-cancer analysis of DIMT1 reveals its prognostic significance and immune-associated characteristics with experimental validation in gastric cancer

Pan-cancer analyses revealed distinct genomic and epigenetic alteration patterns and demonstrated significant associations between DIMT1 expression and immune infiltration profiles, immune regulatory genes, and cancer-type-specific TMB/MSI characteristics in gastric cancer.

S. Liu, Jian Yang, Min Luo · 0 citations
2026

Deciphering the oncogenic role of RRM2 in Glioblastoma multiforme and its modulation by plant derived compounds

Data make RRM2 an attractive therapeutic candidate in GBM and suggest some phytochemicals as potential inhibitors, which provide a logical basis for further experimental validation and creation of new, plant-tailored therapeutic interventions to manage GBM.

S. Singh, Pardeep Yadav, S. K. Jha · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.